| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |